Found 4 matching trials
A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms PHASE1 This study is being conducted to evaluate the safety, tolerability, dose-li...
Show More Location
City of Hope Medical Center
Learn More & Join Trial
A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms PHASE1 This study is being conducted to evaluate the safety, tolerability, and dos...
Show More Status
Active Not Recruiting
Location
Royal Brisbane and Women'S Hospital
Learn More & Join Trial
A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia PHASE3 This study is being conducted to evaluate INCA033989 versus best available ...
Show More Location
Banner Md Anderson Cancer Center
Learn More & Join Trial
A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of INCA033989 Following Subcutaneous or Intravenous Administration in Healthy Adult Participants PHASE1 This study is being conducted to evaluate the pharmacokinetics, safety, and...
Show More Location
Celerion Clinical Research Unit
Learn More & Join Trial